Greylin Investment Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $5.47M | Sell |
44,178
-522
| -1% | -$67.2K | 0.91% | 21 |
|
|
2024
Q1 | $5.9M | Sell |
44,700
-160
| -0.4% | -$19.7K | 0.95% | 19 |
|
|
2023
Q4 | $4.89M | Sell |
44,860
-1,025
| -2% | -$106K | 0.85% | 24 |
|
|
2023
Q3 | $4.72M | Sell |
45,885
-575
| -1% | -$62K | 0.85% | 23 |
|
|
2023
Q2 | $5.36M | Sell |
46,460
-450
| -1% | -$51.1K | 0.97% | 24 |
|
|
2023
Q1 | $4.99M | Sell |
46,910
-35
| -0.1% | -$3.78K | 0.91% | 25 |
|
|
2022
Q4 | $5.21M | Hold |
46,945
| – | – | 0.96% | 23 |
|
|
2022
Q3 | $4.04M | Sell |
46,945
-145
| -0.3% | -$12.9K | 0.84% | 24 |
|
|
2022
Q2 | $4.29M | Sell |
47,090
-125
| -0.3% | -$11.1K | 0.83% | 24 |
|
|
2022
Q1 | $3.87M | Hold |
47,215
| – | – | 0.67% | 27 |
|
|
2021
Q4 | $3.62M | Buy |
47,215
+325
| +0.7% | +$25.9K | 0.68% | 28 |
|
|
2021
Q3 | $3.52M | Hold |
46,890
| – | – | 0.72% | 27 |
|
|
2021
Q2 | $3.65M | Sell |
46,890
-2,240
| -5% | -$167K | 0.71% | 29 |
|
|
2021
Q1 | $3.61M | Sell |
49,130
-105
| -0.2% | -$7.75K | 0.75% | 27 |
|
|
2020
Q4 | $3.84M | Sell |
49,235
-891
| -2% | -$68.1K | 0.9% | 23 |
|
|
2020
Q3 | $3.97M | Sell |
50,126
-2,217
| -4% | -$174K | 1.06% | 18 |
|
|
2020
Q2 | $3.86M | Sell |
52,343
-901
| -2% | -$67.8K | 1.09% | 17 |
|
|
2020
Q1 | $3.91M | Sell |
53,244
-974
| -2% | -$76.5K | 1.22% | 16 |
|
|
2019
Q4 | $4.71M | Sell |
54,218
-5,177
| -9% | -$425K | 1.04% | 18 |
|
|
2019
Q3 | $4.77M | Sell |
59,395
-1,305
| -2% | -$105K | 1.14% | 17 |
|
|
2019
Q2 | $4.86M | Sell |
60,700
-15,663
| -21% | -$1.2M | 1.09% | 17 |
|
|
2019
Q1 | $6.06M | Sell |
76,363
-30,046
| -28% | -$2.25M | 1.36% | 14 |
|
|
2018
Q4 | $7.76M | Sell |
106,409
-135,407
| -56% | -$9.56M | 1.86% | 12 |
|
|
2018
Q3 | $16.4M | Sell |
241,816
-20,226
| -8% | -$1.29M | 3.53% | 7 |
|
|
2018
Q2 | $15.2M | Sell |
262,042
-3,485
| -1% | -$197K | 3.29% | 7 |
|
|
2018
Q1 | $13.8M | Sell |
265,527
-1,068
| -0.4% | -$57.7K | 2.99% | 8 |
|
|
2017
Q4 | $14.3M | Buy |
266,595
+2,803
| +1% | +$155K | 3.1% | 8 |
|
|
2017
Q3 | $16.1M | Sell |
263,792
-19,781
| -7% | -$1.2M | 3.69% | 8 |
|
|
2017
Q2 | $17.3M | Sell |
283,573
-8,573
| -3% | -$522K | 4% | 6 |
|
|
2017
Q1 | $17.7M | Sell |
292,146
-7,588
| -3% | -$460K | 4.11% | 6 |
|
|
2016
Q4 | $16.8M | Sell |
299,734
-3,815
| -1% | -$223K | 4.04% | 8 |
|
|
2016
Q3 | $18.1M | Sell |
303,549
-11,219
| -4% | -$656K | 4.51% | 6 |
|
|
2016
Q2 | $17.3M | Sell |
314,768
-2,017
| -0.6% | -$107K | 4.3% | 7 |
|
|
2016
Q1 | $16M | Sell |
316,785
-4,297
| -1% | -$210K | 4.17% | 7 |
|
|
2015
Q4 | $16.2M | Sell |
321,082
-1,034
| -0.3% | -$52.1K | 4.34% | 8 |
|
|
2015
Q3 | $15.2M | Sell |
322,116
-6,430
| -2% | -$342K | 4.21% | 8 |
|
|
2015
Q2 | $17.8M | Sell |
328,546
-47,852
| -13% | -$2.68M | 4.52% | 6 |
|
|
2015
Q1 | $20.4M | Sell |
376,398
-5,764
| -2% | -$326K | 4.86% | 6 |
|
|
2014
Q4 | $20.7M | Sell |
382,162
-15,583
| -4% | -$868K | 4.88% | 6 |
|
|
2014
Q3 | $22.5M | Sell |
397,745
-45,064
| -10% | -$2.53M | 5.38% | 6 |
|
|
2014
Q2 | $24.4M | Sell |
442,809
-17,867
| -4% | -$975K | 5.9% | 5 |
|
|
2014
Q1 | $25M | Sell |
460,676
-45,572
| -9% | -$2.36M | 6.05% | 4 |
|
|
2013
Q4 | $24.2M | Buy |
+506,248
| New | +$23.1M | 5.98% | 4 |
|
|
2013
Q3 | – | Sell |
-501,637
| Closed | -$22.2M | – | 40 |
|
|
2013
Q2 | $22.2M | Buy |
+501,637
| New | +$22.4M | 7.08% | 5 |
|
Other funds holding MRK
Greylin Investment Management's MRK Position: Q2 2024 in Review
Greylin Investment Management reduced its Merck (MRK) stake by 1.2% in Q2 2024, selling an estimated $67.2K and leaving 44,178 shares worth $5.47M. The position accounts for 0.91% of the portfolio, ranked #21.
Greylin Investment Management first reported a position in MRK in Q2 2013 and has held it in 44 quarters since. The position peaked at $25M in Q1 2014. 3,545 funds tracked by Wall St. Rank hold MRK as of Q2 2024.
- Greylin Investment Management held 44,178 shares of Merck worth $5.47M as of Q2 2024.
- Greylin Investment Management sold 522 Merck shares in Q2 2024, an estimated $67.2K.
- Merck made up 0.91% of Greylin Investment Management's portfolio in Q2 2024, its #21 holding.
- Greylin Investment Management first reported a position in Merck in Q2 2013 and has held it in 44 quarters since.
- Greylin Investment Management's Merck position peaked at $25M in Q1 2014.
- 3,545 funds tracked by Wall St. Rank held Merck as of Q2 2024.
Based on Greylin Investment Management's 13F filing for Q2 2024, filed 19 Jul 2024.